1.Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)
Majidova N, Sari M, Kahvecıglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arikan R, Işık S, Balvan O, Geredeli C, Uygun K, Hacıbekiroğlu I, Kostek O, Bayoğlu İV. Clinicopathologic Features And Efficacy Of Induction Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience. Oncol Res Treat. 2024 Apr 2. doi: 10.1159/000537988. Epub ahead of print. PMID: 38565096.
Arak, H., Erkiliç, S., Yaslikaya, Ş., Mocan, E. E., Aktaş, G., Semiz, H. S., ... & Kuş, T. (2024). The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.Journal of Immunotherapy, 10-1097.
Köstek, O., Demirel, A., Hacıoğlu, M. B., Tastekin, D., Karabulut, S., Gündogdu, A., ... & Cicin, İ. (2024). The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.Journal of Chemotherapy, 1-9.
TUZ, Z., AYDIN, E., FERHATOĞLU, F., SARI, M., PAKSOY, N., DOĞAN, İ., ... & SAİP, P. M. (2024). The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients.Turkish Journal of Medical Sciences,54(1), 229-238.
Bayoğlu, İ. V., Hüseynov, J., Topal, A., Sever, N., Majidova, N., Celebi, A., ... & Çiçin, İ. (2023). PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score.Journal of Clinical Medicine,12(19), 6420.
Yildirim, E. C., Atag, E., Coban, E., Unal, O. U., Celebi, A., Keser, M., ... & Yavuzsen, T. (2023). The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study.The Breast,70, 56-62.
Osman, K., Ahmet, K., Hilmi, T., İlker, N. O., Ercan, Ö., Devrim, Ç., ... & İrfan, Ç. (2023). Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers.Balkan Journal of Medical Genetics,25(2), 5-14.
Atag, E., Gokcay, S., Simsek, E. T., Aslan, F., Yetisir, A. E., & Sari, M. (2023). Syrian Refugee and Turkish Women with Breast Cancer: A Comparison on Clinicopathological Features and Survival.Archives of Iranian medicine,26(1), 29.
Özdemir, Ö., Zengel, B., Yildiz, Y., Uluç, B. O., Cabuk, D., Ozden, E., ... & Alacacioglu, A. (2022). The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.Anti-Cancer Drugs,33(7), 663-670.
Sari, M., Atag, E., Demir, T., Simsek, E. T., Coban, E., & Cikrikcioglu, M. (2022). Deficient Mismatch Repair and Lymphocytic Response to Tumor as Prognostic Markers in Stage II Colon Cancer Patients.Journal of the College of Physicians and Surgeons Pakistan,32(2), 186-193.
Simsek, E. T., Coban, E., Atag, E., Gungor, S., Aker, F., & Sari, M. (2022). The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment.Journal of the College of Physicians and Surgeons--Pakistan: JCPSP,32(2), 181-185.
Simsek, E. T., Coban, E., Atag, E., Gungor, S., Sari, M., & Gurleyik, G. (2021). The Role of FDG PET/CT to Evaluation of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Breast Cancer.Journal of the College of Physicians and Surgeons Pakistan,31(7), 792-798.
Tüzer C, Sari M, Aktaş Çetin E, Ak N, Büyüköztürk S, Çolakoğlu B, Mualla Saip P, Deniz G, Gelincik A. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels. Allergy. 2020 Nov;75(11):2942-2945. doi: 10.1111/all.14311.
Sari M. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option. J Cancer Res Ther. 2020 Jul-Sep;16(4):900-902. doi: 10.4103/jcrt.JCRT_169_19.
Kizildag Yirgin I, Has D, Arslan G, Aydin EC, Sari M, Onder S, Yasemin S, Cabioglu N, Karanlik H, Tukenmez M, Dursun M, Muslumanoglu M, Ozmen V. Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer. Eur J Radiol Open. 2020 Nov 19;7:100286. doi: 10.1016/j.ejro.2020.100286.
Sarı Murat,Aydıner Adnan (2020). Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy. Journal of Cancer Research and Therapeutics, 16(1), 132-138., Doi: 10.4103/jcrt.JCRT_757_19
Sarı Murat,Saip Pınar Mualla (2020). Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life. Indian Journal of Cancer, 57(1), 55-61., Doi: 10.4103/ijc.IJC_458_18
Sarı Murat,Saip Pınar Mualla (2018). Prolonged Disease Control with Nivolumab in Metastatic Lung Adenocarcinoma During Immunotherapy Era. Journal of the College of Physicians and Surgeons Pakistan, 28(11), 891-892., Doi: 10.29271/jcpsp.2018.11.891
Demir Atakan,Molinas Mandel Nil,Paydaş Semra,Demir Osman Gökhan,Er Özlem,Turhal Nazım Serdal,Bavbek Sevil,Eralp Yeşim,Saip Pınar Mualla,Güler Emine Nilüfer,Aydıner Adnan,Oyan Uluç Başak,Kılıçkap Saadettin,Üskent Necdet,Karadurmuş Nuri,Kaplan Mehmet Ali,Yanmaz Mustafa Teoman,Demir Hacer,Alan Özkan,Korkmaz Taner,Olgun Polat,Sönmez Özlem,Altundağ Kadri,Gündüz Şeyda,Günaldı Meral,Sarı Murat,Beypınar İsmail,Başaran Gül (2020). Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptorpositive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial. Balkan Medical Journal, 37(2), 104-107., Doi: 10.4274/balkanmedj.galenos.2020.2019.11.143
Köstek Osman,Hacıoğlu Muhammet Bekir,Sakin Abdullah,Demir Tarık,Sarı Murat,Özkul Özlem,Araz Murat,Doğan Aysun Fatma,Demircan Nazım Can,Uzunoğlu Sernaz,Çiçin İrfan,Erdoğan Bülent (2019). Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?. Cancer Chemotherapy And Pharmacology, 83(1), 115-122., Doi: 10.1007/s00280-018-3713-6
Keskin Serkan,Küçücük Nezihe Seden,Ak Naziye,Atalar Banu,Sarı Murat,Sözen Hamdullah,İbiş Kamuran,Topuz Samet,Saip Pınar Mualla (2019). Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis. Oncology Research and Treatment, 42(3), 101-106., Doi: 10.1159/000494334
Bademler Süleyman,Sarı Murat (2018). A One-center Study of Sixteen Patients with Pregnancy-associated Breast Cancer: Clinicopathological Characteristics and Survival. Anadolu Kliniği Tıp Bilimleri Dergisi, 23(3), 137-142., Doi: 10.21673/anadoluklin.446910
Sarı Murat,Sarı Selma,Nalçacı Meliha (2017). The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma. Turkish Journal of Hematology, 34(2), 131-136., Doi: 10.4274/tjh.2016.0161
Üçüncü M,Serilmez Murat,Sarı Murat,Bademler Süleyman,Karabulut Senem (2019). The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer. Biomolecules, 9(9), 464, Doi: 10.3390/biom9090464
Bademler Süleyman,Zırtıloğlu Alişan,Sarı Murat,Üçüncü Muhammed Zübeyr,Bilgin Elif,Karabulut Senem (2019). Clinical Significance of Serum Membrane-Bound Mucin-2 Levels in Breast Cancer. Biomolecules, 9(2), 40, Doi: 10.3390/biom9020040
Bademler Süleyman,Üçüncü Muhammed Zübeyr,Sarı Murat,Tilgen Yasasever Ceren,Usul Afşar Çiğdem,Taştekin Didem (2019). Role of ınsulın-lıke growth factor 1 (ıgf-1) and ınsulın-lıke growth factor bındıng proteın-3 (ıgfbp-3) ın the dıagnosıs of pancreatıc adenocarcınoma and monıtorıng treatment response. Acta Medica Mediterranea, 35(1), 71-75., Doi: 10.19193/0393-6384_2019_1_12
Bademler Süleyman,Zırtıloğlu Alişan,Sarı Murat,Tilgen Yasasever Ceren,Karabulut Senem (2019). Igf-1 And Igfbp-3 In Colorectal Cancer, An Observatıonal Casecontrol Study. Acta Medica Mediterranea, 35(1), 15-21., Doi: 10.19193/0393-6384_2019_1_1
Bademler Süleyman,Sarı Murat,Üçüncü Muhammed Zübeyr,Serilmez Murat,Karabulut Senem (2018). Clınıcal sıgnıfıcance of serum ınsulın-lıke growth factor-1 (ıgf-1) and ınsulın- lıke growth bındıng proteın-3 (ıgfbp-3) ın patıents wıth gastrıc cancer. Acta Medica Mediterranea, 34(6), 2055-2060., Doi: 10.19193/0393-6384_2018_6_320
Akın Sibel,Sarı Murat,Tufan Fatih,Bahat-Öztürk Gülistan,Saka Bülent,Erten Sebile Nilgün,Karan Mehmet Akif (2014). Is inferior vena caval filter an alternative treatment option for geriatric patients that cannot use anticoagulation therapy?. Aging Clinical and Experimental Research, 26(1), 73-75., Doi: 10.1007/s40520-013-0123-9
2. Uluslararası diğer hakemli dergilerde yayınlanan makaleler
ARIKAN, R., Üstün, H., Demircan, N. A. Z. I. M., Işik, S., Telli, T., Yaşar, A. L. P. E. R., ... & Bayoğlu, İ. B. R. A. H. İ. M. (2023). Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib.Journal of Oncological Science,9(2).
Arikan, R., Telli, T. A., Isik, S., Sari, M., Kostek, O., Ercelep, O., & Bayoglu, I. V. (2023). Evaluation of Clinicopathological Characteristics and Survival Outcomes of Young Gastric Cancer Patients, Single Center Experience.
Atag, E., Sari, M., Coban, E., & Simsek, E. T. (2022). Factors Influencing Mortality of Metastatic Bladder Cancer: A Single-Center Experience.Eurasian Journal of Medical Investigation,6(4).
Simsek, E. T., Coban, E., Atag, E., Sari, M., & Gurleyik, G. (2022). In Which Luminal Breast Cancers Might Neoadjuvant Chemotherapy Be Appropriate to Achieve a Pathological Complete Response in Axillary Lymph Nodes?.
Sarı Murat,Vatansever Sezai (2020). Current Trends in the Incidence of Non-small Cell LungCancer in Turkey: Lung Cancer Aging. Eurasian Journal of Medical Investigation, 4(2), 169- 172., Doi: 10.14744/ejmi.2020.46278
Sarı Murat,Ekenel Meltem,Özlük Mesude Yasemin,Başaran Mert (2020). Clinical and Pathological Features of Ewing Sacoma FamilyTumors in Uro-oncology: A Single-Institute Experience. Eurasian Journal of Medical Investigation, 4(2), 247-252., Doi: 10.14744/ejmi.2020.34964
3.Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler
Sarı Murat (2019). Age-Specıfıc Incıdence Ratıos Of Breastcancer (Bc) In Turkey: Is Bc In Older People decreasıng?. 2. Uluslararası ve 12. Akademik Geriatri Kongresi, (Özet bildiri)
Sarı Murat,Üçüncü Muhammed Zübeyr (2018). Clınıcal Sıgnıfıcance Of Serum Igf-1and Igfbp-3 In Patıents Wıth Esophagealcarcınoma. 8th Internatıonal Gastroıntestınal Cancers Conference, (Özet bildiri).
4.Yazılan uluslararası kitaplar veya kitaplarda bölümler
Onkoloji Hemşireliği Genişletilmiş ve Güncellenmiş 2. Baskı, Bölüm adı:(16 İmmünoterapi) (2020)., Sarı Murat,Karabulut Senem, Nobel Tıp Kitabevleri, Editör:Can Gülbeyaz, Basım sayısı:2, Sayfa Sayısı 1366, ISBN:978-605-335-505-2, Türkçe(Bilimsel Kitap)
Editörlük: Aydıner Adnan,İğci Abdullah,Cabıoğlu Neslihan,İbiş Kamuran,Sarı Murat (2020). Meme Kanseri Tanı-Tedavi-Takip. Nobel Tıp Kitabevleri
5.Ulusal hakemli dergilerde yayınlanan makaleler
Uzuner Arzu,Cöbek Ünalan Pemra,Alibaş Hande,Kılıç İrem,Sarı Murat,Karakoç Elif,Akbarov Akbar (2008). Doctors’ knowledge level and attitudes concerning avian influenza. Marmara Medical Journal, 21(2), 118-126.
Bademler, S., & Sarı, M. (2018). A One-center Study of Sixteen Patients with Pregnancy-associated Breast Cancer: Clinicopathological Characteristics and Survival.Anatolian Clinic the Journal of Medical Sciences,23(3), 137-142.
6. Ulusal bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler
Sarı Murat,Bademler Süleyman (2018). Memenin Primer İnvazif nöroendokrin Karsinomu Agresifmeme Karsinomunun Özgün Bir Alttipi. Sağlık Bilimleri Üniversitesi İç Hastalıkları Kongresi
Sarı Murat,Bademler Süleyman,İlhan Mehmet Burak,Karanlık Hasan,Saip Pınar Mualla (2018). Memenin Filloides Tümörleri: Tek Merkezden 29 Vakanın Klinikopatolojik Analizi. IX. ULusal Haseki Tıp Kongresi
Sarı Murat,Bademler Süleyman,Karanlık Hasan,Saip Pınar Mualla (2018). Geriatrik Meme Kanseri Hastalarındakitedavi Yaklaşımları. 11. Akademik Geriatri Kongresi
Sarı Murat,Bademler Süleyman (2018). Pür ve Mikst Müsinöz Meme Karsinomu: Klinik ve Tedavi Sonuçlarının Karşılaştırılması. 1. İnönü İç Hastalıkları Kongresi
Sarı Murat (2019). Türkiye’de Yaşa Özgü Kolorektal Kanser İnsidansoranları: Yaşlılarda Kolorektal Kanserartmaktadır. 21. Ulusal İç Hastalıkları Kongresi
Paksoy Nail,Sarı Murat,Başaran Mert,Ekenel Meltem (2019). Nüks/Metastatık Baş- Boyun Kanserlerındeplatın Bazlı Kemoterapı Ve Setuksımabtedavısının Etkınlığı: Gerçek Yaşam Verısı. 23. Ulusal Kanser Kongresi
Ak Naziye,Aydın Esra,Ferhatoğlu Ferhat,Tuz Zeynep,Sarı Murat,Doğan İzzet,Saip Pınar Mualla (2019). Meme Kanseri Hastalarında Doğum, Emzirme Öyküsü Ve Emzirme Maruziyetinin Hastalığın Klinik Ve Patolojik Özellikleri Üzerine Etkisi. 15. Ulusal Meme Hastalıkları Kongresi